ASH Increases Investment in Hematology Research and Training
The American Society of Hematology (ASH) posted on X:
“1/8
ASH increased its investment in hematology research & training, which means more opportunities right now to receive funding!
See the thread for open opportunities by career stage.
Help us share!
2/8
Projects below are based in North America. Find global awards here.
You are encouraged to apply for all awards for which you are eligible; however, please note that only one award may be accepted at a time
3/8
Medstudent Funding for a part-time or 1-year immersive project
ASH HIP Medical Student Award | Part-time or immersive project
ASH HONORS | Part time
ASH Physician-Scientist Award | Immersive
4/8
PhD students: Receive $40,000 annually for 2 years of tuition/salary/honorarium, research, & training w/ these opportunities.
ASH Graduate Hematology Award | here
ASH HIP Graduate Student Award | here
5/8
Residents: Receive career mentorship and $5,000 for your part-time research project to take place over 3-12 months with these awards:
ASH HIP Resident Award | here
ASH HONORS | here
6/8
Fellows & junior faculty — Research awards
ASH HIP Fellow Award | $100,000 over 2-3 years for protected research time and training
RTAF | $70,000 for one year protected research time
7/8
Fellows and junior faculty — Training opportunities
Clinical Research Training Institute | In-person and distance learning & mentorship
8/8
The ASH Treating Fairly is a new award for ASH members who are PIs for research on hematologic diseases & disorders disproportionately affecting vulnerable communities.
Protect your research amid federal cuts here.
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH